Srivastava Sapna (CIK 1569226) reported 8 SEC Form 4 insider transactions across 4 companies over the past 18 months (most recent 2026-07-15). Recent activity: Sell NUVL (5,146 shares), Sell NUVL (3,444 shares), Buy ALMS (3,553 shares), Buy NUVL (3,444 shares), Buy AURA (15,000 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-15 | Nuvalent, Inc. (NUVL) | Director | Sell | 5,146 | $638,104 |
| 2026-07-15 | Nuvalent, Inc. (NUVL) | Director | Sell | 3,444 | $0 |
| 2026-07-02 | ALUMIS INC. (ALMS) | Director | Buy | 3,553 | $0 |
| 2026-06-18 | Nuvalent, Inc. (NUVL) | Director | Buy | 3,444 | $0 |
| 2026-06-15 | Aura Biosciences, Inc. (AURA) | Director | Buy | 15,000 | $0 |
| 2025-10-28 | Tourmaline Bio, Inc. (TRML) | Director | Sell | 518 | $0 |
| 2025-06-20 | Nuvalent, Inc. (NUVL) | Director | Buy | 2,647 | $0 |
| 2025-06-18 | Aura Biosciences, Inc. (AURA) | Director | Buy | 13,000 | $0 |
Source: SEC Form 4 filings · as of 2026-07-15